Company / Gross Profit
Nuo Therapeutics, Inc. Gross Profit History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
-$370.0K
FY2017
5-year range
-$370.0K / $3.5M
FY2013-FY2017
Trend
-44.2%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit has fluctuated over the past 7 years, ranging from -$369,997 in FY2017 to $7M in FY2012.
Based on SEC 10-K filings.
-$369,997 in FY2017.
Declined from $4M to -$369,997 over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, gross profit decreased 44.2% year-over-year.
- Peak gross profit was recorded in FY2012.
Company context
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | -$370.0K | -44.2% |
| FY2016 | -$256.6K | -107.2% |
| FY2015 | $3.5M | +257.5% |
| FY2014 | $991.2K | -68.2% |
| FY2013 | $3.1M | -53.1% |
| FY2012 | $6.6M | +47.1% |
| FY2011 | $4.5M | - |
As of FY2017 · SEC 10-K · Updated Jun 29, 2026